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Peptide neurotoxins are powerful tools for research, diagnosis, and
treatment of disease. Limiting broader use, most receptors lack an
identified toxin that binds with high affinity and specificity. This
paper describes isolation of toxins for one such orphan target, KcsA,
a potassium channel that has been fundamental to delineating the
structural basis for ion channel function. A phage-display strategy is
presented whereby ∼1.5 million novel and natural peptides are fab-
ricated on the scaffold present in ShK, a sea anemone type I (SAK1)
toxin stabilized by three disulfide bonds. We describe two toxins
selected by sorting on purified KcsA, one novel (Hui1, 34 residues)
and one natural (HmK, 35 residues). Hui1 is potent, blocking single
KcsA channels in planar lipid bilayers half-maximally (Ki) at 1 nM.
Hui1 is also specific, inhibiting KcsA-Shaker channels in Xenopus
oocytes with a Ki of 0.5 nM whereas Shaker, Kv1.2, and Kv1.3 chan-
nels are blocked over 200-fold less well. HmK is potent but promis-
cuous, blocking KcsA-Shaker, Shaker, Kv1.2, and Kv1.3 channels with
Ki of 1–4 nM. As anticipated, one Hui1 blocks the KcsA pore and two
conserved toxin residues, Lys21 and Tyr22, are essential for high-
affinity binding. Unexpectedly, potassium ions traversing the
channel from the inside confer voltage sensitivity to the Hui1
off-rate via Arg23, indicating that Lys21 is not in the pore. The 3D
structure of Hui1 reveals a SAK1 fold, rationalizes KcsA inhibition,
and validates the scaffold-based approach for isolation of high-
affinity toxins for orphan receptors.
Hui1 toxin | ShK toxin | HmK toxin | sea anemone | NMR
Venomous animals produce neurotoxic peptides for defenseand to capture prey. With potencies in the nanomolar range,
the peptides act by modulating the function of target receptors.
Toxins isolated from venoms have been used to identify and purify
ion channels, to clarify their roles in physiology, to elucidate the
structural basis for their function, and, recently, to diagnose and
treat disease. Given their utility, it is frustrating that natural toxins
cross-react with related receptors (or have no known target) and
that most receptors lack a specific, high-affinity toxin. This state of
affairs is easily understood; the small amounts of toxins isolated
from natural sources makes target identification a challenge and
their purpose in the wild does not favor target specificity. Here, we
advance our approach to overcoming these problems, that is, cre-
ation of expression libraries of toxins allowing cloning based on
target binding (1), by seeking a specific, high-affinity ligand for an
orphan channel receptor.
Our strategy is to start with a known toxin and to design a
phage-display library using the genetic database of its predicted
homologs, in native and combinatorial fashion, so the encoded
peptides share the same structural scaffold. As a proof of concept,
we previously addressed a case of inadequate target discrimination
by known natural toxins using a library of ∼11,200 peptides
designed to share the fold in α-KTx scorpion toxins and a specific
ligand for the human voltage-gated potassium channel Kv1.3 was
isolated (1). Moka1, composed of domains from three scorpion
species, blocks Kv1.3 with nanomolar affinity, allowing it to sup-
press T-cell-mediated immune responses, and is without unwanted
side effects on gastrointestinal motility seen with natural toxins
because it does not cross-inhibit Kv1.1 and Kv1.2. Supporting the
design premise that encoded peptides are expressed, correctly
folded, and accessible on the phage surface in a manner permissive
of sorting based on target binding, the determined 3D structure of
Moka1 revealed it to be constructed on an α-KTx scaffold. Here,
we sought to extend our strategy by testing another scaffold and
creation of a library sufficiently large to achieve isolation of pep-
tides specific for a target with no known ligand.
KcsA is a prokaryotic channel with high potassium conductance
and selectivity (2). The first potassium channel visualized at high
resolution (3), KcsA has a single ion conduction pathway on the
central axis of symmetry formed by four identical subunits, each
with two transmembrane segments and a reentrant pore-forming
loop (TM1-P-TM2). The 3D structure of KcsA confirmed expla-
nations for selective ion permeation and conduction pathway gat-
ing deduced in the period before crystallization and its continued
interrogation has been key to delineating the mechanistic bases for
channel function (4–6). Although described 20 y ago (7), KcsA
remains an orphan target so that studies with peptide toxins have
required production of mutant channels with multiple mutations in
the pore domain (8) or chimeras such as Kv1.3-KcsA, where the
entire KcsA pore domain is replaced by the one in Kv1.3 (9).
To isolate toxins for KcsA, a peptide library was designed
with ∼1,562,750 variants via combinatorial permutation of
sequences related to the sea anemone type I (SAK1) toxin
ShK. Phage sorting was performed on purified, wild-type KcsA
channels. Peptides expressed on the enriched phage were
synthesized and studied by surface plasmon resonance (SPR) to
characterize their binding to purified KcsA and by voltage-clamp
electrophysiology to assess channel blockade. Hui1, a novel and
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specific inhibitor of KcsA, HmK, a natural and promiscuous
blocker, and Hui1 mutants were evaluated to identify toxin
segments and residues responsible for specificity and affinity and
to discern the mechanism of channel inhibition. The 3D struc-
ture of Hui1 determined by NMR, the 1:1 stoichiometry of KcsA
inhibition via a pore-directed mechanism, and the role of two,
canonical “dyad” residues (Lys21 and Tyr22) in high-affinity bind-
ing all met expectations for a SAK1-type toxin. In contrast, the
influence of permeant trans ions (those traversing the channel
after entering from the opposite side of the membrane) on dis-
sociation of Hui1 from its external binding site indicated that
Arg23, a residue with a side chain too bulky to fit snugly into the
potassium conduction pore (10), was responsible for the voltage
dependence of block rather than Lys21. This unexpected role for
Hui1-Arg23 could reflect a new SAK1 binding orientation for the
novel toxin; however, some models have located the ShK dyad Lys
in the outer pore vestibule of Kv1.3 (11) rather than in the narrow
portion of the conduction pathway (12). We posit that Hui1 binds
and blocks like some, and perhaps most, natural SAK1 toxins.
Results
A SAK1 Scaffold Library with Over 1.5 Million Variants. ShK, a SAK1
toxin from Stichodactyla helianthus, was chosen as the lead for
design of the new phage library based on its ability to block many
potassium channels and its physical stability. ShK has 35 residues
including six Cys residues that form three disulfide bonds with a
CysI–CysVI, CysII–CysIV, CysIII–CysV pattern (Fig. 1A) to
yield the distinct SAK1 scaffold (13). Although different in tertiary
structure, ShK blocks voltage-gated potassium channels similarly to
scorpion α-KTx toxins, via binding and occlusion of the ion con-
duction pore (14). Of note, ShK-like domains in other animal
proteins also modulate potassium channel function (15).
The sequence of ShK was used as bait to search venom databases
and 150 sequences with the same predicted arrangement of disul-
fide bonds were chosen (Table S1). To favor preservation of the
scaffold architecture, the sequences were aligned on the conserved
Cys residues and CysIII and CysIV were selected as boundaries for
three combinatorial domains (Fig. 1A). The 150 sequences contain
125, 94, and 133 unique A, B, and C domains, respectively. Oligo-
nucleotides were designed for unidirectional ligation to restrict
permutations to genes encoding peptides with segments in the order
A–B–C, yielding a calculated diversity of 1,562,600 de novo peptides
as well as the 150 parental toxins. The peptides, ranging in length
from 29 to 47 residues, were produced upstream and in-frame with
the gene for phage coat protein pIII, as before (1).
Sorting Yields Novel and Natural Toxins That Bind to Purified KcsA
Channels.Although KcsA was an orphan receptor without known
ligands, we judged it feasible to isolate peptides that bound
with high affinity from the SAK1 library because mutation of
KcsA had previously allowed pore binding of α-KTx scorpion
toxins, demonstrating its conserved structural relationship with
eukaryotic K+ channels (8, 9). KcsA channels were synthesized
as before (16) and used as the target for library screening after
adherence in plastic wells. As before (1), toxin variants were
encoded in-frame with phage particle coat protein pIII, thereby
exposing the peptide on the phage surface. During each round of
panning, phages were incubated in wells precoated with KcsA and
those that associated poorly were separated from those that bound
more avidly by washing. Stably bound phages were eluted from the
wells with triethylamine, amplified, and subjected to another
round of selective panning. After five cycles, DNA sequencing of
170 phagemids revealed that nine novel peptides and one native
toxin (HmK) had been enriched on KcsA from the library of
1.5 million predicted variants (Table S2). Among the 10 peptides,
two A domains, one B domain, and six C domains were repre-
sented. The A domains were from AETX-K and HmK. The B
domain was from HmK and carried the conserved dyad residues
(Lys and Tyr/Phe) that have proven important for high-affinity
binding of the α-KTx (17) and ShK (18, 19) toxin families in po-
tassium channel pores (Fig. 1B). Compared with their starting
abundance in the library, the 10 peptides were enriched from
30,000-fold to 180,000-fold (Table 1 and Table S2). The novel
peptide Hui1 and the native toxin HmK were enriched 140,000-
and 90,000-fold, respectively, and represented 9% and 6% of
the enriched phage. Hui1 phages were enriched ∼8- to 15-fold
per cycle whereas total phage recovery increased ∼12-fold in
wells with KcsA compared with a control protein over the five
cycles (Fig. S1). Of note, the native toxin AETX-K that supplied
the A and C domains in Hui1 to the library was present after
four rounds at ∼1% and lost by the fifth selection cycle.
Three of the novel peptides expressed on the enriched phage
(Hui1, Hui2, and Hui3) and three parental toxins that donated
segments (AETX-K, HmK, and ShK) were synthesized and their
interaction with purified KcsA channels studied using SPR spec-
troscopy. The six peptides showed equilibrium binding affinities that
varied from 1 to 80 nM, whereas Moka1, the α-KTx blocker specific
for Kv1.3 channels, showed no interaction with KcsA (Table S2).
Hui1 had the highest affinity, ∼1 nM. The A and C segments of
Hui1 (Fig. 1B) are derived from AETX-K, an Anemonia erythraea
toxin that inhibits the binding of 125I-α-dendrotoxin to rat
synaptosomal membrane (20) and the B segment from HmK is
a Heteractis magnifica toxin known to inhibit Kv1.2 (21). In
SPR studies, AETX-K and HmK bound to KcsA ∼50-fold and
∼14-fold less well than Hui1, respectively (Table S2).
Hui1 Blocks Single KcsA Channels. KcsA channels were reconstituted
into planar lipid bilayers and single-channel recording was used to
assess the effects of Hui1. To overcome confounding inactivation, a
point mutant (E71A) was introduced into KcsA that yields high
open probability (Po) while retaining other native channel charac-
teristics (16). Channels were reconstituted into liposomes using
Fig. 1. Library design and phage sorting. KcsA channels select phage-
expressing Hui1 and HmK by binding. Phage preparation, library construc-
tion and sorting, and synthesis of KcsA and toxins are described in Materials
and Methods. Single-letter codes for amino acids are standard. (A) SAK1
sequences (150) were aligned on conserved Cys residues (indicated by the
gray highlighting) to define three domains that correspond to ShK residues
Arg1-Gln16, Lys18-Phe27, and Arg29-Cys35, respectively. This yields 125, 94,
and 133 unique A, B, and C domains, respectively (Table S1), which combine
to produce ∼1.5 million ABC peptides. After five rounds of selection on KcsA,
phage enrichment was observed compared with the NeutrAvidin (nAv)
control (Fig. S1). (B) Hui1, a novel toxin isolated from the library, is composed
of residues present in two parental toxins, AETX-K (blue) and HmK (green).
Under each of the three domains in Hui1 is indicated its frequency of rep-
resentation (in percent) among the 10 peptides enriched by phage selection
on KcsA (Table S2).
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Escherichia coli lipids, fused into the bilayer, and studied under
activating conditions (pHin 4.0, pHext 7.4 with symmetrical 100 mM
KCl) by described methods (22). Without toxin, single KcsA-E71A
channels had a Po of ∼0.98 at 100 mV (Fig. 2A). Adding 0.25 nM
Hui1 to the external chamber induced long, nonconducting events.
As the level of Hui1 increased, the channel Po decreased. Fitting
the Po/toxin concentration relationship estimated the Ki of Hui1 for
KcsA-E71A channels to be 0.93 ± 0.09 nM with a Hill coefficient of
0.99 ± 0.03, consistent with the expected 1:1 blocking mechanism of
toxin via binding to the external face of the channel (Fig. 2B). In
contrast, 50 nMHui1 added into the internal chamber had no effect
on the open probability of KcsA-E71A (0.98 ± 0.01, n = 3).
Hui1 Blocks KcsA Specifically. To facilitate investigation of the effects
of voltage and ionic conditions on parameters of Hui1 blockade,
we transplanted the KcsA pore into a Shaker voltage-gated K+
channel modified by N-terminal deletion to be noninactivating
(KcsA-Shaker). As described by others (23), each subunit in this
chimera carries the four transmembrane spans that form the
Shaker channel voltage-sensing domain (S1–S4) but the native
S5-P-S6 pore-forming segments are replaced by KcsA residues;
fortunately, four of the hybrid subunits assemble in Xenopus
oocytes to create functional channels, allowing ready assess-
ment of currents using two-electrode voltage clamp. Hui1 was
found to block KcsA-Shaker potently and reversibly (Fig. 3A and
Table 1); fitting the dose–response relationship yielded a Ki for
Hui1 of ∼0.5 nM with a Hill coefficient of 0.93 ± 0.05 (Fig. 3C),
similar to the parameters determined on bona fide KcsA channels
in bilayers. Hui1 was also found to be specific for KcsA-Shaker,
showing 200-fold lower potency on Shaker and two other voltage-
gated K+ channels, Kv1.2 and Kv1.3 (Table 1). Demonstrating
that KcsA-Shaker in oocytes does not faithfully recapitulate the
target used for phage sorting, the parent toxin AETX-K that
bound 50-fold less well than Hui1 to pure KcsA (Table S2)
blocked the chimera as potently as Hui1 and with greater
specificity (Table 1).
The A Domain Mediates Specific Block of KcsA. Suggesting a role for
the A domain in specific block of KcsA by Hui1, Hui3 carries
the A domain in Hui1 (provided by AETX-K) and was similarly
specific, whereas Hui2 has the A domain from HmK and was
similarly promiscuous (Table 1). Further, ShK blocked KcsA-
Shaker 100-fold less well than Hui1, and this was rationalized
by four nonconservative differences between the two toxins in
their A domains. Changing the sites in Hui1 individually to the
residue in ShK produced mutant peptides that each inhibited
KcsA-Shaker less effectively; thus, loss of potency for Hui1-
Lys3Ile, Hui1-Glu10Arg, and Hui1-Arg15Gln explained ∼75% of
the difference in inhibition between the two toxins (Table 2).
Table 1. Novel and parental toxin blockade of KcsA and other K+ channels
Six peptide toxins were synthesized and their inhibition of the indicated channels at equilibrium (Ki ± SEM) were determined by two-electrode voltage clamp
(TEVC) as described in Fig. 3 with kinetic parameters assessed at 0 mV; ND, not determined; n = 5–24 oocytes. The on-rate and off-rate with KcsA-Shaker for Hui1
were kon = 1.1 × 10
6 ± 0.2 × 106/Ms and koff = 7.6 × 10
−4 ± 0.4 × 10−4/s, whereas for ShK they were kon = 1.6 × 10
6 ± 0.2 × 106/Ms and koff = 5.8 × 10
−2 ± 0.8 × 10−2/s;
for HmK they were kon =1.3 × 10
6 ± 0.1 × 106/Ms and koff = 1.4 × 10
−3 ± 0.3 × 10−3/s, and for AETX-K theywere kon= 2.0 × 10
6 ± 0.4 × 106/Ms and koff = 4.7 × 10
−4 ±
0.6 × 10−4/s. The kinetic parameters with Shaker for Hui1 were kon = 5.0 × 10
5 ± 0.3 × 105/Ms and koff = 3.0 ×10
−2 ± 0.3 × 10−2/s, and for ShK they were kon = 1.3 ×
107 ± 0.2 × 107/Ms and koff = 1.4 ×10
−2 ± 0.3 × 10−2/s. The values with Kv1.3 for Hui1 were kon = 7.0 × 10
5 ± 1.2 × 105/Ms and koff = 4.8 × 10
−2 ± 0.9 × 10−2/s, and for
ShK they were kon = 2.7 × 10
7 ± 0.4 × 107/Ms and koff = 1.3 × 10
−3 ± 0.1 × 10−3/s, respectively. Repeats are independent isolations of the same sequence in the fifth
round of sorting on KcsA (170 phages studied). In total, phages enriched on KcsA in the fifth round included nine novel toxins (Hui1-9) and HmK (green text), a
native toxin (Table S2); ShK was not isolated in any panning round, whereas AETX-K (blue text) was lost after the fourth sorting. Removing the N-terminal residue
from ShK yields a toxin (ShK-ΔArg1) that inhibits KcsA-Shaker slightly more effectively (34 ± 6.0 nM).
Fig. 2. Block of single KcsA channels by Hui1. Recordings of single KcsA-E71A
channels at 100 mV with 100 mM symmetric KCl (external pH 7.4, internal pH 4.0)
with Hui1 added at the levels indicated to the external chamber. (A) Representa-
tive recordings with no toxin and three concentrations of Hui1 are shown. The Po
of KcsA-E71A decreased from 0.98 ± 0.01 to 0.15 ± 0.02 as Hui1 concentration
increased from 0 to 5 nM. (B) Po as a function of added Hui1 (n = 3 for each
concentration) fit to the Hill relationship, Po = (Po, max)/(1+ Ki/[Tx])
h, where Po is the
open probability, Po, max is the maximally obtained value for Po, Ki is the inhibition
constant, [Tx] is the concentration of Hui1, and h is the Hill coefficient. The Ki of
Hui1 for KcsA-E71A channels was estimated from the fit to be 0.93 ± 0.09 nMwith
h = 0.99 ± 0.03. Values aremean ± SEM. Some error bars are smaller than symbols.
Zhao et al. PNAS | Published online December 1, 2015 | E7015
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One of these sites has been implicated in tight binding of ShK to
Kv1.3 (24) and carries an opposite charge in Hui1 (ShK-Arg11
versus Hui1-Glu10). The fourth major difference between the two
toxins in the A domain, an additional N-terminal residue in ShK,
justified the remaining loss in affinity. Thus, eliminating Arg1 from
ShK produced a somewhat more potent inhibitor (Table 1) whereas
adding an Arg0 to Hui1 decreased blockade slightly (Table 2).
The B domain of Hui1 carries the dyad residues that are critical
for high-affinity binding of known SAK1 toxins to potassium
channels (Fig. 1B). As expected, these residues, Lys21 and Tyr22,
were important for Hui1 inhibition of KcsA (Table 2). Thus, a
neutralizing mutation to produce Hui1-Lys21Asn decreased block
40-fold and altering the adjacent aromatic residue to create Hui1-
Tyr22Ala decreased affinity over 8,000-fold. In addition, the
conservative mutation of Hui1-Ser19 to Ala decreased inhibition
∼90-fold, a finding consistent with the impact of the homologous
residue in ShK (Ser20) on block of Kv1.3 (25). Notwithstanding its
role in affinity, the B region cannot be inferred to bestow speci-
ficity to Hui1 because HmK is homologous in this region and
did not discriminate among the channels, inhibiting KcsA-
Shaker, Shaker, Kv1.2, and Kv1.3 all with nanomolar affinity
(Table 1).
We do not implicate the C domain of Hui1 in specific block of
KcsA-Shaker for four reasons. First, the domain varied most
widely, although modestly, among the phage isolated on KcsA
(Table S2). Second, both Hui2 and Hui3 block KcsA-Shaker with
high affinity despite carrying the C domain provided by ShK, a
toxin that blocks the channel poorly (Table 1). Third, a non-
conservative mutation in the domain to produce Hui1-Lys28Ala
retained high affinity for KcsA-Shaker (Table 2). Finally, the
NMR structure of Hui1 (discussed below) shows domain C
residues on the opposite side of the toxin from those that most
affect target binding.
Arg23, Not Lys21, Mediates the Voltage Dependence of Hui1 Block.
Hui1 block of KcsA meets expectations for a pore-directed
toxin (26–28) whereby one molecule occludes the conduction
pathway. Thus, the dose–response for Hui1 inhibition showed a
Hill coefficient of ∼1 in studies of both single KcsA-E71A
channels in planar bilayers and KcsA-Shaker channels in oocytes
(Figs. 2B and 3C). Further, the Hui1 on-rate with KcsA-Shaker
was dependent on toxin concentration in a linear manner and
consistent with diffusion limitation (1.1 × 106 ± 0.2 × 106/Ms),
whereas toxin off-rate was insensitive to added toxin (7.6 × 10−4 ±
0.4 × 10−4/s) (Fig. 3 B and D), as expected for a simple bio-
molecular interaction (28).
CTX blockade is sensitive to voltage because the positively
charged e-amino group of its dyad Lys enters the external portion of
Fig. 3. Hui1 is a potent, specific, and voltage-dependent blocker of KcsA. KcsA-Shaker and other ion channels as indicated were expressed in oocytes and studied by
two-electrode voltage clamp to assess equilibrium inhibition and kinetic blocking parameters using a holding voltage of −80 mV, 300-ms test pulses, and a 10-s
interpulse interval (Tables 1 and 2), n = 6–12 cells for each condition. Values are mean ± SEM. Some error bars are smaller than symbols. (A) Representative current
traces for KcsA-Shaker channels at steady state before (control), in the presence of 2 nMHui1 (Hui1), and after toxin washout (wash) with steps of 10 mV from −80mV
to 80 mV. (B) The time course for block and unblock of KcsA-Shaker on acute application (bar) and washout of 2 nM Hui1. Peak currents recorded at 0 mV; every third
point is shown. (C) Dose–response relationships for Hui1 inhibition of KcsA-Shaker (●) and Shaker (▲) studied as in B and fit to the Hill relationship, Fun = (1 +
([Tx]/Ki)
h)−1, where Fun is the fraction of unblocked current at equilibrium, Ki is the dissociation constant, h is the Hill coefficient, and [Tx] is the concentration of Hui1.
The Ki of Hui1 for KcsA-Shaker channels was estimated from the fit to be 0.50 ± 0.03 nMwith h = 0.93 ± 0.05. (D) Effect of Hui1 concentration on blocking kinetics of
KcsA-Shaker. The apparent first-order rate constants for association (♦, On, kon[Tx]) and dissociation (△, Off, koff) are plotted as a function of Hui1 concentration using
the protocol in B. (E) Effect of voltage on Hui1 blocking kinetics of KcsA-Shaker channels. Each parameter was measured with test steps from −20 mV to 40 mV and
normalized to its value at 0 mV; ♦, kon; Δ, koff; ●, Ki. On-rate and off-rate time constants were determined by single-exponential fits to the time course for block or
unblock on acute application or washout of 5 nM Hui1. The inhibition constant Ki was calculated from the fraction of unblocked current at equilibrium and the rate
constants (Materials andMethods). (F) Effect of voltage on blockade of KcsA-Shaker by Hui1 mutants. Ki for each toxin was determined from −20 mV to 40 mV based
on the fraction of unblocked current at equilibrium (Fun) and plotted as a ratio to the value at 0 mV. The change in Ki with voltage is due to altered off-rate.
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the conduction pathway and interacts with potassium ions traversing
the pore from the intracellular (trans) compartment (10, 17, 28, 29).
This mechanism has also been proposed for the ShK (12). Un-
expectedly, neutralization of Hui Lys21 had no effect on the voltage
dependence of toxin off-rate. Thus, the off-rate of Hui1 from KcsA-
Shaker was sensitive to voltage with an effective valence (zδ) of ∼0.3
(Fig. 3E) and Hui1-Lys21Asn showed the same zδ as the wild-type
toxin (Fig. 3F). In contrast, neutralization of Arg23 to produce Hui1-
Arg23Ala eliminated the voltage dependence of toxin off-rate (Fig.
3F) even though the mutation had little effect on toxin affinity
(Table 2). Supporting a role for a positively charged residue at
position 23, the conservative mutation Hui1-Arg23Lys decreased but
did not eliminate the voltage dependence of blockade (zδ ∼0.14),
again with limited effect on affinity. The impact of Arg23 but not
Lys21 on the voltage dependence of Hui1 was observed also when
the mutant peptides were applied to a KcsA-Shaker channel variant
that had a zδ for wild-type Hui1 of ∼0.6 (Fig. S2).
To confirm that the voltage dependence of Hui1 block was
due to trans ion enhanced toxin dissociation, the kinetics of Hui1
inhibition of KcsA-Shaker were studied with various levels of
added monovalent cations inside the oocytes (Fig. 4), a conve-
nient method that is crude compared with ionic reconstitution
without cellular constituents, but effective (30, 31). As expected,
increasing the concentration of intracellular potassium from
∼90 mM to 190 mM did not modify Hui1 on-rate but did speed
toxin off-rate in a manner linearly dependent on the amount of
microinjected potassium. In contrast, similar increases in the
level of intracellular sodium, lithium and N-methyl glucamine
(NMG), three impermeant cations, had no effect on either the
on-rate of Hui1 or dissociation of the toxin from its extracellular
site. Consistent with interaction of Hui Arg23 and ions traversing
the pore, Hui-Arg23Ala was insensitive to increased levels of
either intracellular potassium or NMG, whereas Hui-Arg23Lys
was sensitive but less so than wild-type Hui1.
Hui1 Employs a SAK1 Scaffold. The 3D solution structure of Hui1
was determined by well-established NMR methods (32) to assess
the structural basis for toxin function. A total of 324 distance and
dihedral constraints resulted in an Hui1 solution structure with
an rmsd of 0.46 (1.02) Å for the polypeptide backbone (all heavy
atoms) (Fig. 5A, Fig. S3, and Tables S3 and S4). Superimposition
of Hui1 and ShK showed that Hui1 retained a SAK1 scaffold
despite containing three segments from two SAK1 parents.
Structural similarity between Hui1 and ShK was strongest in the
central helix-kink-helix motif (Hui residues 13–25) spanning do-
mains A and B, showing a backbone rmsd value of 0.76 Å between
the two toxins whereas the value overall was 1.41 Å (Fig. 5B). The
C domain showed the greatest structural difference between the
two toxins, forming a short C-terminal helix (Hui1 residues 28–31)
that had a more open conformation and different orientation for
the Cys17-Cys32 bond in Hui1, but had a limited impact on
function, presumably because of its distance from residues medi-
ating binding and specificity.
Our results have linked the A domain with specificity and the B
domain with high-affinity binding (Tables 1 and 2). Comparing the
structures of Hui1 and ShK in these domains (Fig. 5C), we observed
that the side chains of Hui1 residues that contribute strongly to
binding (Ser19, Lys21, and Tyr22; Table 2), as well as Arg23 that is
responsible for the voltage dependence of blockade (Fig. 4), cluster
in the B domain and superimpose with the analogous residues of
ShK. In contrast, the three nonconservative differences between
Hui1 (Lys3, Glu10, and Arg15) and ShK (Ile4, Arg11, and Gln16)
as well as ShK-Arg1, absent from Hui1, all lie in the A domain.
Structural similarity is lower in the A domain, consistent with a
role in determining selectivity, and yet comparable side-chain
orientations are exhibited in the two toxins (Fig. 5D). We also
evaluated the electrostatic surface potential of Hui1 and ShK,
observing similar patterns for the B and C domains and notable
differences in the A domain (Fig. 5 E and F). Although the two
toxins differ by only a single charge overall (in keeping with
their similar on-rates; Table S2), the surface of the A domain is
positive in ShK and mixed in Hui1, primarily due to Hui1-
Glu10. In light of the strong structural resemblance of the two
proteins, electrostatic differences seem to play an important role
in determining binding selectivity mediated by the A domain.
Discussion
Peptide Toxin Phage Display for Orphan Receptors. Peptide toxins
isolated from venoms have been useful to identify ion channel
subtypes in tissues and subcellular locales, to reveal the roles
channels play in physiology, and to delineate mechanism, for
example, to correlate structure, including conformational changes,
Table 2. Inhibition of KcsA-Shaker by Hui1 variants
Toxin Ki, nM Variant/Hui
Hui1 0.50 ± 0.03 =1
Hui1-Arg0 0.7 ± 0.1 1.4
Hui1-Lys3Ile 0.9 ± 0.1 1.8
Hui1-Glu10Arg 4.1 ± 0.4 8.2
Hui1-Arg15Gln 2.6 ± 0.5 5.2
Hui1-Ser19Ala 46 ± 3.5 92
Hui1-Lys21Asn 20 ± 2.0 40
Hui1-Tyr22Ala 4,260 ± 860 8,520
Hui1-Arg23Ala 0.25 ± 0.05 0.5
Hui1-Arg23Lys 0.45 ± 0.03 0.9
Hui1-Lys28Ala 0.40 ± 0.14 0.8
Equilibrium inhibition constants (Ki ± SEM) were determined by two-elec-
trode voltage clamp as described in Fig. 3 (n = 5–12 oocytes). To test the
influence of nonconservative differences between Hui1 and ShK on block-
ade, Hui1 toxins were produced with an added Arg0 or the changes Lys3Ile,
Glu10Arg, or Arg15Gln. Hui1 residues Ser19, Lys21, Tyr22, and Arg23 were stud-
ied based on the importance of analogous residues in other SAK1 toxins.
Fig. 4. Hui1-Arg23 is responsible for voltage-dependent block. KcsA-Shaker
was expressed in oocytes and studied by two-electrode voltage clamp to assess
equilibrium inhibition and kinetic blocking parameters by the protocol in Fig. 3
at 0 mV after microinjection of 40 nL of 0.25 M to 1 M of the indicated salt
(Tables 1 and 2). The change in Ki with voltage was due to changes in toxin
dissociation rates. The dissociation rate of Hui1 was increased by microinjected
KCl, but not by NMGCl, NaCl, or LiCl. The dissociation rate of Hui-Arg23Ala was
insensitive to microinjected KCl or NMGCl, whereas the dissociation rate of Hui-
Arg23Lys was less sensitive to microinjected KCl than wild-type Hui1. Oocyte
solute space has been estimated to be ∼400 nL and intracellular potassium
concentration to be ∼90 mM; therefore, a 20 nmol KCl microinjection should
raise intracellular potassium by ∼50 mM to 140 mM, leading to an 11-mV shift
in EK and a 50% increase in outward current (30, 31), close to the observed
values here of 10 ± 2 mV and a 45 ± 9% (n = 4–6 oocytes). The new Ki were
stable during the period of recording, that is, from 30 to 120 min after mi-
croinjection. Values are mean ± SEM.
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and function (27, 33, 34). Recently, peptide toxins have also
gained use in medical practice both as diagnostic tools and as
therapeutics (35, 36), notably to treat intractable pain through ion
channel blockade (37). The study of channels without known
toxins has sometimes been made possible by pore transplantation
(9) or multisite mutations that allow toxin blockade (38), but
neither strategy is useful to examine native channels. Although
scorpions, spiders, snakes, sea anemones, and cone snail venoms
all contain peptides that target ion channels (39–41), the small
amounts of toxins in venom make purification and target iden-
tification a challenge.
The emergence of genomic and proteomic databases for ven-
oms suggested to us the potential for development of a high-
throughput screen to select among toxins expressed on phage for
desired attributes. Thus, despite the enormous number of natural
peptide toxins extrapolated from genetic studies (>12 million), a
limited number of resilient scaffolds that tolerate wide residue
diversity are used (42). Further supporting the utility of phage
display, peptide toxins are small (∼20–100 residues) and stabilized
by two to five disulfide bridges. To originally test the strategy of
combining structure-based peptide design and the power of phage
display, we considered the case of Kv1.3, a channel with known
natural peptide toxin ligands that were inadequately specific.
Construction and sorting of a library with ∼104 native and de novo
peptides sharing a scorpion α-KTx scaffold allowed isolation of
Moka1, a specific Kv1.3 blocker (1).
In this paper, we advance the strategy, creating a library of
over 106 peptides on a scaffold from sea anemone and isolate
Hui1, a de novo toxin specific for KcsA, an orphan target without
previously known ligands. The NMR structure of Hui1 shows the
SAK1 scaffold used to design the peptides in the library has been
recapitulated. The structural basis for the affinity and specificity
of Hui1 were explored through comparison of its function as a
KcsA channel inhibitor, including studies of the basis for voltage-
dependent blockade, with Hui1 mutants and the related toxins,
Hui2, Hui3, HmK, AETX-K, and ShK.
Voltage-Sensitive Block by Pore-Directed Toxins. Whereas Hui1
blocks the KcsA pore in a simple bimolecular manner, Arg23 on
the toxin interaction surface, rather than a canonical Lys, was
found to confer sensitivity to voltage. This was unexpected be-
cause CTX blocks classical potassium channels such that Lys27
enters the pore to impede passage of potassium ions (26–28).
This endows CTX off-rate with dependence on membrane
voltage due to electrostatic repulsion between permeating po-
tassium ions in the conduction pathway and the basic Lys resi-
due. Neutralization of CTX Lys27 abolishes the dependence of
toxin off-rate on voltage (17, 28, 29), whereas neutralizing two
Arg residues on the CTX interaction surface does not (17). This
mechanism was recently visualized in a crystal structure of CTX
in complex with a voltage-gated potassium channel—the long
alkyl side chain and the hydrogens of e-amino group of Lys27
were noted to be uniquely suited for close contact with the
carbonyl oxygens in the first (S1) potassium ion site in the pore
filter, unlike the terminal guanidinium group of Arg, and was
observed to alter distribution of potassium ions in the conduction
pathway (10).
Although some have proposed that ShK Lys22 binds in the
Kv1.3 selectivity filter (12), this remains a matter of controversy.
Molecular dynamic simulations have modeled ShK Lys22 in the
external vestibule of Kv1.3 away from the narrow filter region
(11), as we posit here for Hui1 Lys21 with KcsA. Suggesting a
pore location, weak energetic coupling of ShK Lys22 and a Tyr in
the selectivity filter of Kv1.3 has been observed using mutant
cycle analysis (14); however, weak coupling is also consistent
with interaction through an intervening residue (10). Consistent
with localization of ShK Lys22 in the outer vestibule rather than
the filter of a Ca2+-activated potassium channel, mutant cycle
analysis showed coupling of potassium in the external bath so-
lution and the toxin residue (25). Whereas neutralization of CTX
Lys27 (17, 28, 29) and Hui1 Arg23 (Fig. 4) produces toxins that
dissociate in a voltage-insensitive manner and no longer show
“knock-off” by trans ions, we are not aware of similar studies with
ShK Lys22 in support of its proximity to the Kv1.3 selectivity
filter. ShK bearing a charge-reversing unnatural amino acid at
position 22 was modeled with the residue in the outer vestibule
of Kv1.3 (18). These disparate observations are consistent with
the notion that SAK1 toxins do not locate Lys in the selectivity
filter or that they bind with multiple orientations. Of note, a
Fig. 5. Structure of Hui1 by NMR in comparison with the ShK toxin. The Hui1
structure was determined from 324 distance and dihedral constraints derived
from homo- and heteronuclear 2D-NMR spectra (Materials and Methods, Fig.
S3, and Table S3). (A) Hui1 structure (PDB ID code 2N6B). The 25 lowest-energy
structures obtained from distance-geometry/simulated annealing determination
are shown. (B) Superposition of Hui1 (orange) and crystal structure of ShK (4LFQ,
residues 2–35, gray) based on alignment of the central helix-kink-helix motif
(Hui1 residues 13–25) shows Hui1 retains an ShK-like scaffold. Side chains of
Hui1 residues 21–23 are shown. Comparing Hui1 to an NMR structure of
ShK (Fig. S4) suggests lower structural similarity between the two toxins.
(C) Comparison of Hui1 and ShK side chains showing four residues contrib-
uting to the channel-binding surface. Domains A (blue), B (green), and C (blue-
purple), as identified in Table 1, are indicated by translucent color rendering;
domain C is on the backside and visible in D. (D) Comparison of Hui1 and ShK
side chains in the A domain that contribute to altered affinity of the two
toxins for KcsA-Shaker (Table 2) with surface coloring as in C. The orientation is
related to C by the indicated 60° turn around the horizontal axis. (E) Elec-
trostatic surface rendering of Hui1 colored according to interpolated charge
(red/blue = negative/positive) oriented as in C using the Discovery Studio 3.0
suite (Accelrys). Side chains of the four binding-site and three nonconserved
amino acid differences between Hui1 and ShK are shown. (F) Electrostatic
surface rendering of ShK (residues 2–35, 4LFQ) with coloring code, orientation,
and side chains homologous to Hui1 in E.
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role for Hui1 Arg23 is consistent with inhibition of Kv1.3 by an
ShK peptidomimetic bearing the three-residue B domain epi-
tope Lys-Tyr-Arg (24).
What can we surmise about Hui1 residues Lys21-Tyr22 -Arg23
relative to the KcsA pore before structural determination of this
bimolecular complex? Because neutralization of Hui1 Arg23, but
not of Lys21, abolishes voltage dependence of KcsA-Shaker
blockade, we infer that Arg23 is closer to the selectivity filter than
Lys21. Given that the S1 potassium binding site in KcsA is similar
in size and geometry to that in the voltage-gated potassium
channel studied by Banerjee et al. (10), Hui1-Arg23 is too large
to fit snugly into the site, suggesting the residue is in the vesti-
bule. Supporting a less intimate association of Hui1-Arg23 and
the narrow portion of the conduction pathway, the conservative
mutation CTX-Lys27Arg destabilized binding to a Kv channel
∼1,000-fold (43), whereas Hui1-Arg23Ala had only a 0.5-fold
effect on affinity (Table 2). Consistent with a weaker interaction
with ions in permeation pathway, the voltage dependence of
Hui1 block of KcsA was about half that of CTX with a Kv
channel (28) and the smaller position 23 residue in Hui1-
Arg23Lys yielded a toxin with decreased sensitivity to trans ions,
as if the charged side-chain was even more distant from ions
traversing the pore. Also consonant with a vestibule location for
Hui-Arg23 at some distance from the pore, the voltage de-
pendence of Hui dissociation was doubled by a mutation in the
KcsA vestibule and neutralization of Arg23 (but not of Lys21)
again ablated the effect of voltage (Fig. S2). Because the mu-
tations Hui-Lys21Asn and Hui-Tyr22Ala decreased affinity so
significantly, ∼40-fold and 8,000-fold, respectively (Table 2), we
hypothesize these dyad residues interact intimately with residues
in the KcsA vestibule.
Structural Context for the Interaction of Hui1 and KcsA. The elec-
trophysiology data establish that the Hui1 B domain is mandatory
for tight binding to KcsA (explaining its uniform representation
among the phage enriched from the library) whereas the more
variable A domain and channel specificity are intimately related
(Table 1). That four sequence differences between Hui1 and ShK
alter the charge of the site (Arg0, Lys3/Ile4, Glu10/Arg11, and
Arg15/Gln16) and that each contributes to the ∼100-fold differ-
ence in their affinity for KcsA (∼10, 10, 50, and 30%, respectively)
makes clear that channel recognition is a function of several non-
dominating influences and implicates electrostatic differences in
the A domain as important for toxin specificity. However, the
common reflection of electrostatics is on the kinetics of complex
formation, and on-rate of the two toxins for KcsA-Shaker is similar,
whereas the Hui1 off-rate is ∼75-fold slower, indicative of more
stable binding (Table 1). More consistent with expectations, the
higher affinity of ShK for Shaker and Kv1.3 was due in large
measure to enhanced on-rates that were ∼26-fold and ∼39-fold
faster than Hui1. Naturally, verification of molecular explanations
for channel specificity, the promiscuity of HmK, and trans ion-
enhanced toxin dissociation mediated by Arg rather than Lys re-
main speculative until the relevant toxin–channel cocomplex
structures are elucidated.
Effect of Target Milieu on Toxin Binding. It is thought-provoking, and
perhaps serendipitous, that Hui1 demonstrates such similar affinity
for KcsA (∼1 nM) studying binding to purified protein in de-
tergent by SPR (Table S2), blockade of single KcsA-E71A chan-
nels in planar lipid bilayers (Fig. 2), and inhibition of KcsA-Shaker
channels expressed in oocytes (Table 1) because the three assays,
ionic conditions, and target constructs vary and pore-directed
peptide toxins often show differences in affinity for the same target
in different environments. Thus, AgTX2, a scorpion α-KTx family
toxin, inhibits the toxin-sensitive KcsA mutant KcsA3M-Shaker
expressed in oocytes with subnanomolar affinity (23) but binds to
purified KcsA3M three orders of magnitude less well (8). Indeed,
the effects of environment on target conformation and target–toxin
interaction may explain the unexpected behavior of AETX-K, the
toxin that donated its A and C domains to Hui1. AETX-K binds to
pure KcsA with an affinity 50-fold lower than Hui1 as judged by
SPR (Fig. S1), an observation that rationalizes its presence at low
levels after four rounds of phage panning but its loss in the fifth
cycle. In contrast, AETX-K inhibits with high affinity and even
greater specificity than Hui1 when KcsA is linked to the S1–S4
domains of Shaker and expressed in the plasma membrane of
oocytes (Table 1). The higher affinity of Hui1 for pure KcsA
suggests it is preferable for biophysical studies, our purpose in
seeking a toxin here, whereas AETX-K may prove useful to dif-
ferentiate KcsA-Shaker from mammalian channels in cell mem-
branes. Although these contextual effects have not interfered with
use of purified targets to select toxins active on channels in bi-
ological membranes, here or in the past (1), the findings highlight
the important role of target milieu on phage selection and
toxin activity.
Hui1 is specific for KcsA, an example of achieving target speci-
ficity by driving selection for high affinity, as seen with Moka1 (1).
Conversely, HmK is promiscuous, demonstrating that sorting for
high-affinity binding does not demand high specificity (Table 1). The
small α-KTx library that yielded Moka1 did not show enrichment on
KcsA (1); given greater library diversity, we suspect that an α-KTx–
based toxin could also be designed to block KcsA. The isolation of
Moka1 on an α-KTx scaffold (1), and Hui1 on SAK1 toxin scaffold,
supports the notion that other scaffolds will also be amenable to
sorting novel and natural peptides, allowing analogous work on other
channels and different types of membrane receptors important to
human health and disease.
Materials and Methods
Library Construction. The sequence of ShK was used as template for BLAST
searching of the UniProt and Pfam database (44, 45). The combinatorial library
was built based on 150 SAK1 sequences (Table S1). Three domains were defined
by the third and fourth of the six conserved Cys residues that form disulfide
bridges, allowing for insertions and deletions (Fig. 1) and the 150 SAK1 se-
quences provided 125, 94, and 133 unique sequences for domains A, B, and C,
respectively (Table S1). Nucleotides duplexes encoding the third and fourth Cys
were ligated unidirectionally to produce toxin genes with only an ABC pattern.
Complementary nucleotide pairs for each unique domain were synthesized,
phosphorylated, and annealed individually. To achieve and monitor domain
incorporation, 94 separate reactions were performed to ligate the ABC inserts
into pAS62 in-frame with phage particle coat protein pIII, as before (1). Each
reaction contained one B domain, 125 A domain duplexes, and 133 C domain
duplexes with equimolar amounts of A, B, and C. Ligation mixtures were
transformed into SS320 Electrocompetent Cells (Lucigen). Sequencing of 376
plaques supported unbiased insert utilization.
Library Screening. Three wells in a NUNC-Immuno MaxiSorp 96-well plate
(Thermo Fisher Scientific) were coated overnight at 4 °C with 1 μg of KcsA in
50 μL of 100 mMNaHCO3 per well, 1 mM n-dodecyl-β-d-maltopyranoside (DDM,
pH 9.0). Another three wells were coated in the same buffer with NeutrAvidin
(Life Technologies), a deglycosylated form of avidin, as the negative control.
Wells were washed twice with TBS (25 mM Tris·HCl, 140 mM NaCl, 3 mM KCl,
and 1 mM DDM, pH 7.4) containing 0.1% Tween 20 and 0.5% BSA (TBSTB) and
then blocked with TBS containing 2% BSA (TBSB) before washing twice more
with TBSTB. For each well, an equal number of library phage particles, from 108
to 1010, were added in 50 μL TBSB and incubated on a rocking shaker for 1 h.
Poorly adherent phage particles were removed bywashing three to five timeswith
200 μL TBSTB. Bound phage particles were eluted with 100 μL of 0.1 M triethyl-
amine by incubation for 10 min on a rocking shaker. The pH of the eluate was
adjusted to between 7.0 and 8.5with 1MTris·HCl (pH 8.0) and used to infect E. coli
XL1-Blue for phage amplification. Phage particles were quantified by titering be-
fore and after selective library sorting and genotyped by DNA sequencing.
KcsA and Toxin Production. KcsA andKcsA-E71Awere producedwith a C-terminal
hexahistidine-tag, as before (5), for phage panning, SPR, and reconstitution
into planar lipid bilayers. Briefly, KcsA-E71A mutation was produced using a
Quickchange Site-Directed Mutagenesis kit (Agilent Technologies) and
confirmed by DNA sequencing. KcsA proteins were expressed in E. coli
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BL21 (DE3) cells and extracted with 100 mM KCl, 50 mM DM, and 20 mM
Tris·HCl, pH 7.5, and then purified by cobalt-affinity and size-exclusion
chromatography. Hui1 (KR608403), Hui2 (KR608404), Hui3 (KR608405), HmK
(O16846), AETX-K (Q0EAE5), ShK (P29187), and mutant Hui1 peptides were
produced with CSBio. Folding reactions were quenched by acidification and
products purified by reverse-phase HPLC, as before (1). Toxin concentrations
were determined using a spectrophotometer. Toxin peptides were synthe-
sized in solid state, folded, and purified by HPLC. Fractions with the desired
protein were identified by analytical LC-MS, judged to be more than 95%
pure, and lyophilized before storage at −80 °C.
SPR Spectroscopy. Binding kinetics were determined using a BIAcore-3000 with
immobilization of 600–1,000 response units of KcsA on a Ni-NTA chip via the
C-terminal hexahistidine tag (GE Healthcare). KcsA protein was purified as
previously described (5) and stored at 4 °C in 150 mMKCl, 50 mM Tris-Cl, 1 mM
DDM, pH 7.5, before use. Peptide toxins were studied by applying 60 μL of five
serial dilutions between 0.25–10 nM in running buffer (10 mM Hepes, 150 mM
NaCl, 3 mM KCl, 50 μM EDTA, and 0.005% Tween 20, pH 7.4). Toxin binding
was corrected by subtraction of responses on a blank flow cell. Association and
dissociation kinetics were studied with a flow rate of 25 μL·min−1. Data were
fitted with a 1:1 Langmuir model to estimate kon and koff using BIAevaluation
3.1 software; Kd values were calculated from the ratio of koff and kon. The
binding parameters for Hui1 were validated using a ProteOn XPR36 Protein
Interaction Array System (BioRad).
Single KcsA Channel Recording. Liposomes were formed with KcsA-E71A from
a solution of 35 mM CHAPS, 20 mg/mL E. coli polar lipids (Avanti Polar Lipids),
and 1 μg KcsA/mL in reconstitution buffer (200 mM KCl and 10 mMMops, pH
7.0) by dialysis against reconstitution buffer at room temperature, and the
resulting suspension of liposomes frozen at −80 °C in 50-μL aliquots. For
recording, a liposome aliquot was diluted with 50 μL of 1.5 M KCl, refrozen,
thawed, and then sonicated for 10 s in a cylindrical bath sonicator. Single
channels were recorded at room temperature in a horizontal planar bilayer
system with two aqueous chambers separated by an 80-μm-thick partition
hand-crafted from overhead transparency film, as described (22). Briefly,
bilayers were formed of POPE/POPG (7.5:2.5 mg/mL in n-decane) on a 50-μm
hole. The “internal” chamber contained 100 mM KCl adjusted to pH 4.0 with
succinic acid and the “external” chamber contained the 100 mM KCl, 10 mM
Mops adjusted to pH 7.0 with KOH. The pH gradient ensures that channels
operate here with the cytoplasmic side of the protein facing the internal
solution. Current was recorded with an Axopatch-200B amplifier (Molecular
Devices) with signals sampled at 10 kHz after low-pass filtering (eight-pole
Bessel, 0.75- to 1-kHz corner frequency). Single-channel recordings were
obtained by squirting 0.5 μL of a liposome suspension onto the internal side
of the bilayer and waiting 2–5 min. On appearance of a channel (at 100 mV),
chambers were perfused with fresh solutions. After recording for 3 min to
confirm proper channel characteristics, 0.25–5 nM Hui1 toxin was perfused
across the external solution. Recordings were idealized using Clampfit and
filtered at 300 Hz before analysis.
Two-Electrode Voltage Clamp. Xenopus laevis oocytes were injected with cRNA
encoding KcsA-Shaker (23), KcsA-E71A-Shaker, Shaker (NM_167596, the variant
used here is the noninactivating variant Shaker-IR Δ6–46), human Kv1.2
(NM_004974), and human Kv1.3 (NM_002232) carried in a laboratory vector
with the 5′ and 3′ portions of the Xenopus laevis β-globin gene, a cytomega-
lovirus promoter for expression in mammalian cells, and a T7 promoter for in
vitro transcription. Recording solution was (in millimolar): 10 KCl, 90 NMDG, 1
MgCl2, 0.3 CaCl2, 10 Hepes, pH 7.5, with 0.1% BSA (Fraction V). Recordings were
performed with constant gravity flow of solution at 2 mL/min yielding chamber
exchange in ∼5 s. Currents were recorded 1–3 d after cRNA injection using an
Oocyte clamp amplifier OC-725C (Warner Instruments) and electrodes filled
with 3 M KCl with resistance of 0.3–1 MΩ. Data were filtered at 1 kHz and
digitized at 20 kHz using pClamp software and assessed with Clampfit v9.0
and Origin 6.0. Equilibrium inhibition for Hui1 was determined by fitting dose–
response curves whereas it was calculated for other toxins from the fraction of
unblocked current achieved by one to three toxin concentrations that inhibited
20–80% of the current.
kon and koff were estimated from fits of the kinetics of toxin wash-in and
wash-out calculated. Thus, according to a bimolecular scheme with a single
toxin-bound state and rapid changes in toxin concentration compared with
the speed of block and unblock, one can assess steady-state and kinetic
parameters of blockade, as before (28, 38). Thus, the unblocked fractional
current at equilibrium (Fun) with a toxin concentration [Tx] relates to the dose
dependence of inhibition according to Fun = (1 + [Tx]/Ki)
−1; Fun is related to the
second-order association rate constant kon (M
−1·s−1) and first-order dissociation
rate constant koff (s
−1) according to Fun = koff/(kon[Tx] + koff); and the equi-
librium inhibition constant for half-maximal blockade is Ki = koff/kon. Time
constants determined by single exponential fits of the inhibition of current on
toxin wash-in and its restoration on wash-out are related to these parameters
by τon = (kon[Tx] + koff)−1 and τoff = (koff)−1. Because τoff is a direct measure of
the dissociation rate constant it provides an internal validation of the de-
termined kinetic parameters.
NMR Spectroscopy and Structure Determination. LyophilizedHui1was dissolved
to a final concentration of 0.6–0.7 mM in phosphate buffer (20 mM, pH 6.6)
containing 10 mM NaCl and 0.02% NaN3 in 7% or 99%
2H2O. NMR spectra
were collected on a Bruker DRX700 spectrometer equipped with cryogenic
triple-resonance TCI probe with z axis pulsed field gradients. All experiments
were conducted at 16.4 T and 298 K. Resonance assignments and structural
restraints (distances and dihedral angles) were obtained from 2D homonuclear
and heteronuclear spectra (Fig. S3) and secondary chemical shift analysis using
TALOS (46). Detailed experimental conditions are provided in Supporting In-
formation. Structure calculation was performed using the CNS (Crystallography
and NMR System) software (47) using distance-geometry and simulating
annealing protocols. Calculations were performed iteratively, introducing short-
range and later long-range distance constraints, followed by dihedral con-
straints, to eliminate erroneous assignments. Structure quality of the final
ensemble was validated by the PROCHECK_NMR program (48). Statistics of the
final structures are in Table S4.
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